Results 151 to 160 of about 61,475 (266)
ABSTRACT Background We aimed to develop models for predicting programmed death‐ligand 1 (PD‐L1) expression following neoadjuvant chemoradiotherapy (nCRT) in esophageal squamous cell carcinoma (ESCC) using a multifaceted approach that integrates traditional radiomics, deep learning, and machine learning.
Hyun Do Jung +6 more
wiley +1 more source
Applications of Artificial Intelligence in Cancer Diagnosis and Treatment
This review explores how AI and multimodal data fusion transform oncology through enhanced screening, precision diagnosis, and personalized therapy. By dissecting core challenges—including data bias and explainability—it provides a strategic framework for the digital transformation and ethical implementation of AI in clinical cancer care.
Yifeng Xie +6 more
wiley +1 more source
TME remodeling and clinical challenges of immune checkpoint blockade in nasopharyngeal carcinoma. [PDF]
Ou C, Qi L, Lai H, Ye J, Tian X, Li Z.
europepmc +1 more source
ABSTRACT Purpose Patients unable to receive cisplatin due to age, comorbidities, or reduced performance status are commonly treated with concurrent radiotherapy (RT) and cetuximab. This study evaluated the prognostic significance of the Geriatric 8 (G8) score and the Charlson Comorbidity Index (CCI) in predicting survival outcomes in this population ...
Esin Kiraz +5 more
wiley +1 more source
Prognostic Value and Therapeutic Implications of MRI-Based Negative Lymph Nodes in Nasopharyngeal Carcinoma. [PDF]
Lin ZQ +12 more
europepmc +1 more source
ABSTRACT Background TNM‐9 Stage IB nasopharyngeal carcinoma (NPC) encompasses markedly heterogeneous risk profiles, yet lacks reliable biomarkers to guide the choice between de‐escalation and intensification strategies. This study aimed to explore the prognostic significance of upper‐ and middle‐neck nodal involvement (UNI and MNI) in this population ...
Hanchuan Xu +13 more
wiley +1 more source
Harnessing the immune microenvironment: advances in nasopharyngeal carcinoma immunotherapy. [PDF]
Zhu Y, Liu Y, Yin Z, Ou C, Guo X, Zhu X.
europepmc +1 more source
ABSTRACT The third reported case of synchronous colorectal adenocarcinoma and EBV‐positive DLBCL in an 87‐year‐old patient confirms the rarity of this synchronous tumor. Despite segmental resection, the patient died from postoperative complications, highlighting the need for multidisciplinary research into pathogenesis and management.
Fen Liu +3 more
wiley +1 more source
T cell fate regulation in EBV‑associated nasopharyngeal carcinoma (Review). [PDF]
Zhang L, Ding S, Chen D, Cai B, Mu Z.
europepmc +1 more source

